Sosnowski, Jerzy published the artcileMethod for obtaining sustained-release antazoline hydrochloride tablets, Recommanded Product: N-Benzyl-N-((4,5-dihydro-1H-imidazol-2-yl)methyl)aniline hydrochloride, the publication is Farmacja Polska (1985), 41(9), 524-9, database is CAplus.
Hydrophilic matrix tablets containing antazoline-HCl (I) [2508-72-7] were prepared by incorporation of hydroxpropyl Me cellulose [9004-65-3]. Thus, double-layer tablets were obtained containing both the drug with an extended releasing rate (incorporated in the hydrophilic matrix) and the same drug with normal releasing rate. The release rate of I from these tablets was estimated by the half-exchange method.
Farmacja Polska published new progress about 2508-72-7. 2508-72-7 belongs to imidazoles-derivatives, auxiliary class Inhibitor,Immunology/Inflammation,Histamine Receptor, name is N-Benzyl-N-((4,5-dihydro-1H-imidazol-2-yl)methyl)aniline hydrochloride, and the molecular formula is C8H11BO2, Recommanded Product: N-Benzyl-N-((4,5-dihydro-1H-imidazol-2-yl)methyl)aniline hydrochloride.
Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem